The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a 5,000 member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations.

The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a 5,000-member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations.

ASPET members work in a variety of different fields and include neuroscientists, toxicologists, chemical biologists, pharmacists, cardiovascular scientists, and many more.

Though very diverse, our members have a common bond through their membership in ASPET. Our members’ research efforts help develop new medicines and therapeutic agents to fight existing and emerging diseases.

ASPET publishes four highly respected and widely read journals that provide rapid publication and easy access on mobile devices, tablets, and desktop computers. The Society copublishes a wholly open access journal with the British Pharmacological Society and Wiley. Since the launch of JPET in 1909, ASPET has provided scientists in pharmacology and related fields with leading primary research and review articles. ASPET members have access to all journal content as a member benefit.

• Drug Metabolism and Disposition
• The Journal of Pharmacology and Experimental Therapeutics
• Molecular Pharmacology
• Pharmacological Reviews

Request Information / Trial